Phase 1 Non-cystic Fibrosis Bronchiectasis Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

Chronic Obstructive Pulmonary DiseaseNon-cystic Fibrosis Bronchiectasis

Genentech, Inc.128 enrolled7 locationsNCT06603246

Recruiting

Phase 1

A Clinical Study of RSS0343 in Healthy Subjects

Non-cystic Fibrosis Bronchiectasis

Reistone Biopharma Company Limited48 enrolled1 locationNCT07289464